Search research articles
Contact Us
Filters
Showing results (81-90 of 208) with videos related to
Page
of 21
Sort By:
The Prostate
|
January 24, 2025
Baseline Imaging Derived Factors of Response Following [225Ac]Ac-J591 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Lesion Level Analysis
Judith Stangl-Kremser, Andres Ricaurte-Fajardo, Sandra Huicochea Castellanos, et al.
Prostate Cancer and Prostatic Diseases
|
September 27, 2024
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2)
Anthony V Serritella, Amy Taylor, Michael C Haffner, et al.
Prostate Cancer and Prostatic Diseases
|
October 1, 2024
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)
Andrew J Armstrong, Amy Taylor, Michael C Haffner, et al.
BJU International
|
December 16, 2010
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma
Patrick Schöffski, Jorge A Garcia, Walter M Stadler, et al.
European Urology
|
May 20, 2011
New therapies for castration-resistant prostate cancer: efficacy and safety
Himisha Beltran, Tomasz M Beer, Michael A Carducci, et al.
JCO Oncology Practice
|
November 13, 2023
Penile Cancer: EAU-ASCO Collaborative Guidelines Update Q and A
Oscar R Brouwer, R Bryan Rumble, Benjamin Ayres, et al.
The Prostate
|
January 5, 2022
Pilot study of the diagnostic utility of <sup>89</sup> Zr-df-IAB2M and <sup>68</sup> Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer
Panagiotis J Vlachostergios, Muhammad J Niaz, Charlene Thomas, et al.
Cancer Chemotherapy and Pharmacology
|
August 8, 2013
Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)
Hielke J Meulenbeld, Johann S de Bono, Scott T Tagawa, et al.
The Prostate
|
January 19, 2021
Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted β-emitting radionuclide therapies in metastatic castration-resistant prostate cancer
Panagiotis J Vlachostergios, Muhammad Junaid Niaz, Myrto Skafida, et al.
Frontiers in Oncology
|
March 8, 2021
Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
Panagiotis J Vlachostergios, Muhammad Junaid Niaz, Michael Sun, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 208) with videos related to
Sort By:
Page
of 21
The Prostate
|
January 24, 2025
Baseline Imaging Derived Factors of Response Following [225Ac]Ac-J591 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Lesion Level Analysis
Judith Stangl-Kremser, Andres Ricaurte-Fajardo, Sandra Huicochea Castellanos, et al.
Prostate Cancer and Prostatic Diseases
|
September 27, 2024
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2)
Anthony V Serritella, Amy Taylor, Michael C Haffner, et al.
Prostate Cancer and Prostatic Diseases
|
October 1, 2024
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)
Andrew J Armstrong, Amy Taylor, Michael C Haffner, et al.
BJU International
|
December 16, 2010
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma
Patrick Schöffski, Jorge A Garcia, Walter M Stadler, et al.
European Urology
|
May 20, 2011
New therapies for castration-resistant prostate cancer: efficacy and safety
Himisha Beltran, Tomasz M Beer, Michael A Carducci, et al.
JCO Oncology Practice
|
November 13, 2023
Penile Cancer: EAU-ASCO Collaborative Guidelines Update Q and A
Oscar R Brouwer, R Bryan Rumble, Benjamin Ayres, et al.
The Prostate
|
January 5, 2022
Pilot study of the diagnostic utility of <sup>89</sup> Zr-df-IAB2M and <sup>68</sup> Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer
Panagiotis J Vlachostergios, Muhammad J Niaz, Charlene Thomas, et al.
Cancer Chemotherapy and Pharmacology
|
August 8, 2013
Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)
Hielke J Meulenbeld, Johann S de Bono, Scott T Tagawa, et al.
The Prostate
|
January 19, 2021
Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted β-emitting radionuclide therapies in metastatic castration-resistant prostate cancer
Panagiotis J Vlachostergios, Muhammad Junaid Niaz, Myrto Skafida, et al.
Frontiers in Oncology
|
March 8, 2021
Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
Panagiotis J Vlachostergios, Muhammad Junaid Niaz, Michael Sun, et al.
Page
of 21